ABBV vs AMGN
By Alex · Tickerpine
AbbVie Inc. vs Amgen Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | ABBV | AMGN |
|---|---|---|
| Price | $253.35 | $358.33 |
| Market cap | $447.62B | $193.39B |
| P/E ratio | 123.6 | 24.9 |
| ROE | — | 101.32% |
| Profit margin | 5.79% | 20.96% |
| Revenue growth | 12.40% | 5.80% |
| Dividend yield | 2.73% | 2.81% |
| Beta | 0.31 | 0.42 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
ABBV vs AMGN in plain English
- ABBV is the bigger company — about 2.3× the market cap of AMGN.
- AMGN is cheaper on earnings (P/E 24.9 vs 123.6).
- ABBV is growing revenue faster (12% vs 6%).
- AMGN has the higher dividend yield (2.81% vs 2.73%).
How would $1,000 have done in each?
ABBV return calculator
See what $1,000 in AbbVie Inc. would be worth today.
AMGN return calculator
See what $1,000 in Amgen Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.